Cytrellis Biosystems

Series-B+
cytrellis.com Biotech & Healthcare Woburn, United States Founded 2012 51-100
Total Funding $78.5M
Latest Round $50M Series-B+
Last Announced Sep 21, 2021
Investors 7 Backers
Decision Makers 6 Verified

About Cytrellis Biosystems

FDA-Cleared Micro-Coring ® Technology.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Woburn, United States
Year Founded 2012
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website cytrellis.com
Domain Registered Date Feb 13, 2012

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $50,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $28,500,000 · Series-B+

  3. Milestone

    Website domain registered

    cytrellis.com

  4. Milestone

    Company founded

    Woburn, United States

Investors & Backers

7
ARCH Venture Partners
Biomatics Capital Partners
D1 Capital Partners
Merz Venture Initiative
Partner Fund Management
PFM Health Sciences
Sands Capital Ventures

Funding History

2 Rounds
Series-B+ · Sep 21, 2021
Series-B+ · Jun 5, 2018
$28,500,000 Source

Founders & Leadership

5

Diane Marcou

CFO

Work email & phone locked Unlock →

Doug Levinson

Founder

Work email & phone locked Unlock →

Jackson McAdam

Chief Financial Officer

Work email & phone locked Unlock →

Rox Anderson

Founder, Medical / Technology Advisor

Work email & phone locked Unlock →

Shiv Sabesan

Chief Technology Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts